Shark predation on migrating adult american eels (Anguilla rostrata) in the Gulf of St. Lawrence.

In an attempt to document the migratory pathways and the environmental conditions encountered by American eels during their oceanic migration to the Sargasso Sea, we tagged eight silver eels with miniature satellite pop-up tags during their migration from the St. Lawrence River in Québec, Canada. Surprisingly, of the seven tags that successfully transmitted archived data, six were ingested by warm-gutted predators, as observed by a sudden increase in water temperature. Gut temperatures were in the range of 20 to 25°C-too cold for marine mammals but within the range of endothermic fish. In order to identify the eel predators, we compared their vertical migratory behavior with those of satellite-tagged porbeagle shark and bluefin tuna, the only endothermic fishes occurring non-marginally in the Gulf of St. Lawrence. We accurately distinguished between tuna and shark by using the behavioral criteria generated by comparing the diving behavior of these two species with those of our unknown predators. Depth profile characteristics of most eel predators more closely resembled those of sharks than those of tuna. During the first days following tagging, all eels remained in surface waters and did not exhibit diel vertical migrations. Three eels were eaten at this time. Two eels exhibited inverse diel vertical migrations (at surface during the day) during several days prior to predation. Four eels were eaten during daytime, whereas the two night-predation events occurred at full moon. Although tagging itself may contribute to increasing the eel's susceptibility to predation, we discuss evidence suggesting that predation of silver-stage American eels by porbeagle sharks may represent a significant source of mortality inside the Gulf of St. Lawrence and raises the possibility that eels may represent a reliable, predictable food resource for porbeagle sharks

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Background: The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods: International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results: ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≤ 18 years: 69, 48, 23; 85%), older adults (≥ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P < 0.001). The most common atypical presentations under 60 years of age were nausea and vomiting and abdominal pain, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country. Interpretation: This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men

Le métabolisme des céramides hypothalamiques induit une résistance à l’insuline centrale et une dérégulation de l’homéostasie glucidique durant l’installation de l’obésité

Studies show that hypothalamic lipid accumulation in the hypothalamus is responsible for the development of central lipotoxicity, a phenomenon that could play a role in the installation of peripheral insulin resistance and type II diabetes by deregulating the nervous control of glucose homeostasis. It is known that the accumulation of ceramides is involved in the development of lipotoxicity of peripheral tissues. The objective of this study is to determine the role of the hypothalamic ceramide metabolism on the installation of a central insulin resistance and to study the mechanisms involved on this phenomenon. We also determined the role of hypothalamic ceramide metabolism in the deregulation of obesity induced glucose homeostasis.The installation of a central insulin resistance is studied using in vitro approaches using hypothalamic GT1-7 mouse cells treated with palmitate for 24 hours. An in vivo approach use Obese Zucker rats were perfused with myriocin (an inhibitor of de novo synthesis of ceramides) in ICV for 21 days. Insulin sensitivity and glucose tolerance tests are performed. At the end of treatment, they receive an ICV injection of insulin, insulin sensitivity and ceramide levels are quantified in the hypothalamus. Islets of Langerhans are isolated for insulin secretion tests.In GT1-7 cell line, palmitate induces insulin resistance which is accompanied by an accumulation of ceramides. In the presence of myriocin, ceramides are no longer accumulated and the insulin resistance induced by palmitate is counteract. Using an inhibitor of PKC ζ and an adenovirus encoding a dominant-negative of PKC ζ, we have shown thatpalmitate is no longer able to induce insulin resistance despite the presence of an accumulation of ceramides. In the obese Zucker rat, we have demonstrated an accumulation of hypothalamic ceramides which is counteract by myriocin. This is associated with an improvement in insulin sensitivity in the hypothalamus. Interestingly, these animals improvetheir glucose tolerance which is associated with an increase in parasympathetic tone leading to an increase in insulin secretion. Islets of Langerhans isolated from these rats have increased secretory capacity when treated with myriocin.Our study reveals that hypothalamic lipotoxicity is associated with an accumulation of ceramides in this structure, responsible for the installation of insulin resistance. These results also highlight the key role of ceramide metabolism at the hypothalamus level in the deregulation of nervous control of obesity-induced carbohydrate homeostasis. Ω3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are known to have beneficial effects on peripheral insulin sensitivity to saturated fatty acids. In mice fed with high fat diet, we shown that DHA supplementation can delay the installation of DT2. In GT1-7 cell line, DHA, the enzyme responsible for its production, elongase 2 (Elovl2), and EPA are able to counteractdeleterious effects induced by palmitate by modulating the ceramide metabolism.Des études montrent que l’accumulation de lipides dans l’hypothalamus serait responsable de l’installation d’une lipotoxicité centrale : phénomène qui pourrait jouer un rôle dans l’apparition d’une insulino-résistance périphérique et du diabète de type II en dérégulant le contrôle nerveux de l’homéostasie glucidique. L'accumulation des céramides est connue pour être impliquée dans le développement d’une lipotoxicité des tissus périphériques. L’objectif de cette étude est de déterminer le rôle du métabolisme des céramides hypothalamiques dans l’installation d’une insulino-résistance centrale et d'étudier les mécanismes impliqués mais également de déterminer le rôle du métabolisme de ces céramides hypothalamiques dans la dérégulation de l’homéostasie glucidique induite par l’obésité.L’installation d'une insulino-résistance centrale est étudiée à l'aide d'approches in vitro, en utilisant des cellules hypothalamiques de souris GT1-7 traitées avec du palmitate pendant 24h. Pour une approche in vivo, des rats Zucker obèses ont été perfusés avec la myriocine (inhibiteur de la synthèse de novo des céramides) en ICV pendant 21 jours, des tests de sensibilité à l'insuline et de tolérance au glucose sont réalisés. A la fin du traitement, les rats Zucker reçoivent une injection ICV d'insuline, puis la sensibilité à l’insuline ainsi que les taux de céramides sont quantifiés dans l’hypothalamus, les îlots de Langerhans sont isolés pour des tests de sécrétion d'insuline.Dans les cellules GT1-7, le palmitate induit une insulino-résistance qui s’accompagne d’une accumulation de céramides. En présence de myriocine, les céramides ne sont plus accumulés et l’insulino-résistance induite par le palmitate est contre-carrée. En utilisant un inhibiteur de la PKC ζ et un adénovirus codant pour un dominant-négatif de la PKC ζ, nousavons montré que le palmitate n'est plus capable d'induire une insulino-résistance et ce malgré la présence d'une accumulation de céramides. Chez le rat Zucker obèse, l’accumulation de céramides hypothalamiques est contre-carrée par la myriocine. Ce résultat est associé avec une amélioration de la sensibilité à l’insuline dans l’hypothalamus. Defaçon, intéressante, ces animaux améliorent leur tolérance au glucose, amélioration liée à une augmentation du tonus parasympathique conduisant à une augmentation de la sécrétion d’insuline. Les îlots de Langerhans isolés à partir de ces rats présentent une capacité sécrétoire augmentée lors du traitement avec la myriocine.Notre étude révèle que la lipotoxicité hypothalamique est associée à une accumulation de céramides dans cette structure, responsable de l’installation d’une insulino-résistance. Ces résultats mettent également en évidence le rôle clé du métabolisme des céramides au niveau de l’hypothalamus dans la dérégulation du contrôle nerveux de l’homéostasieglucidique induit par l’obésité. Les acides gras polyinsaturés ω3, tel que l’acide eicosapentaénoïque (EPA) et l’acidedocosahexaénoïque (DHA), à l’inverse des acides gras saturés, sont connus pour avoir des effets bénéfiques sur la sensibilité à l’insuline à la périphérie. Chez des souris sous régime enrichi en lipides, nous avons montré qu’une supplémentation en DHA permet de retarder l’installation du DT2. Dans les cellules GT1-7, le DHA, dont l’enzyme responsable de sa production est l’élongase 2 (Elovl2), et l’EPA sont capables de contre-carrer les effets délétères induits par le palmitate en modulant le métabolisme des céramides

Hypothalamic ceramide metabolism induces central insulin resistance and dysregulation of glucose homeostasis during installation of obesity

Des études montrent que l’accumulation de lipides dans l’hypothalamus serait responsable de l’installation d’une lipotoxicité centrale : phénomène qui pourrait jouer un rôle dans l’apparition d’une insulino-résistance périphérique et du diabète de type II en dérégulant le contrôle nerveux de l’homéostasie glucidique. Il est connu que l'accumulation des céramides est impliquée dans le développement d’une lipotoxicité des tissus périphériques. L’objectif de cette étude est de déterminer le rôle du métabolisme des céramides au niveau hypothalamique dans l’installation d’une insulino-résistance centrale et d'en étudier les mécanismes impliqués. Nous avons également déterminé le rôle du métabolisme des céramides hypothalamiques dans la dérégulation de l’homéostasie glucidique induite par l’obésité.L’installation d'une insulino-résistance centrale est étudiée à l'aide d'approches in vitro, en utilisant des cellules hypothalamiques de souris GT1-7 traitées avec du palmitate pendant 24h. L'action de l’insuline est mesurée par la quantification d’Akt phosphorylée (western blot). Les céramides sont quantifiées par lipidomique, l'expression d’ARNm des gènes codant pour les enzymes de la voie de synthèse de novo des céramides par qRT-PCR. Des rats Zucker obèses sont perfusés avec la myriocine (inhibiteur de la synthèse de novo des céramides) en ICV pendant 21 jours. Des tests de sensibilité à l'insuline et de tolérance au glucose sont réalisés. A la fin du traitement, ils reçoivent une injection ICV d'insuline, la sensibilité à l’insuline ainsi que les taux de céramides sont quantifiés dans l’hypothalamus. Les îlots de Langerhans sont isolés pour des tests de sécrétion d'insuline.Nous avons mis en évidence une insulino-résistance dans la lignée hypothalamique GT1-7 traitées avec le palmitate qui s’accompagne d’une accumulation de céramides. En présence de myriocine, les céramides ne sont plus accumulés et le l’insulino-résistance induite par le palmitate est contre-carrée. En utilisant un inhibiteur de la PKCζ et un adénovirus codant pour un dominant-négatif de la PKCζ, nous avons montré que le palmitate n'est plus capable d'induire une insulino-résistance et ce malgré la présence d'une accumulation de céramides. Chez le rat Zucker obèse, nous avons mis en évidence une accumulation de céramides hypothalamiques qui est contre-carrée par la myriocine. Ceci est associé avec une amélioration de la sensibilité à l’insuline dans l’hypothalamus. De façon, intéressante, ces animaux améliorent leur tolérance au glucose qui est associée à une augmentation du tonus parasympathique conduisant à une augmentation de la sécrétion d’insuline. Les îlots de Langerhans isolés à partir de ces rats présentent une capacité sécrétoire augmentée lors du traitement avec la myriocine.Au final, notre étude révèle que la lipotoxicité hypothalamique est associée à une accumulation de céramides dans cette structure, responsable de l’installation d’une insulino-résistance. Ces résultats mettent également en évidence le rôle clé du métabolisme des céramides au niveau de l’hypothalamus dans la dérégulation du contrôle nerveux de l’homéostasie glucidique induit par l’obésitéStudies show that hypothalamic lipid accumulation is responsible for the development of central lipotoxicity, a phenomenon that could play a role in the installation of peripheral insulin resistance and type II diabetes by deregulating the nervous control of glucose homeostasis. It is known that the accumulation of ceramides is involved in the development of lipotoxicity of peripheral tissues. The objective of this study is to determine the role of the hypothalamic ceramide metabolism on the installation of a central insulin resistance and to study the mechanisms involved on this phenomenon. We also determined the role of hypothalamic ceramide metabolism in the deregulation of obesity-induced glucose homeostasis.The installation of a central insulin resistance is studied using in vitro approaches using hypothalamic GT1-7 mouse cells treated with palmitate for 24 hours. The action of insulin is measured by the quantification of phosphorylated Akt (western blot). The ceramides are quantified by lipidomic assay, mRNA expression of genes encoding enzymes of de novo synthesis pathway of ceramides by qRT-PCR. Obese Zucker rats were perfused with myriocin (an inhibitor of de novo synthesis of ceramides) in ICV for 21 days. Insulin sensitivity and glucose tolerance tests are performed. At the end of treatment, they receive an ICV injection of insulin, insulin sensitivity and ceramide levels are quantified in the hypothalamus. Islets of Langerhans are isolated for insulin secretion tests.We have demonstrated that palmitate is able to induce insulin resistance in the hypothalamic GT1-7, which is accompanied by an accumulation of ceramides. In the presence of myriocin, ceramides are no longer accumulated and the insulin resistance induced by palmitate is counteract. Using an inhibitor of PKCζ and an adenovirus encoding a dominant-negative of PKCζ, we have shown that palmitate is no longer able to induce insulin resistance despite the presence of an accumulation of ceramides. In the obese Zucker rat, we have demonstrated an accumulation of hypothalamic ceramides which is counteract by myriocin. This is associated with an improvement in insulin sensitivity in the hypothalamus. Interestingly, these animals improve their glucose tolerance which is associated with an increase in parasympathetic tone leading to an increase in insulin secretion. Islets of Langerhans isolated from these rats have increased secretory capacity when treated with myriocin.In conclusion, our study reveals that hypothalamic lipotoxicity is associated with an accumulation of ceramides in this structure, responsible for the installation of insulin resistance. These results also highlight the key role of ceramide metabolism at the hypothalamus level in the deregulation of nervous control of obesity-induced carbohydrate homeostasi

Brain Ceramide Metabolism in the Control of Energy Balance

The regulation of energy balance by the central nervous system (CNS) is a key actor of energy homeostasis in mammals, and deregulations of the fine mechanisms of nutrient sensing in the brain could lead to several metabolic diseases such as obesity and type 2 diabetes (T2D). Indeed, while neuronal activity primarily relies on glucose (lactate, pyruvate), the brain expresses at high level enzymes responsible for the transport, utilization and storage of lipids. It has been demonstrated that discrete neuronal networks in the hypothalamus have the ability to detect variation of circulating long chain fatty acids (FA) to regulate food intake and peripheral glucose metabolism. During a chronic lipid excess situation, this physiological lipid sensing is impaired contributing to type 2 diabetes in predisposed subjects. Recently, different studies suggested that ceramides levels could be involved in the regulation of energy balance in both hypothalamic and extra-hypothalamic areas. Moreover, under lipotoxic conditions, these ceramides could play a role in the dysregulation of glucose homeostasis. In this review we aimed at describing the potential role of ceramides metabolism in the brain in the physiological and pathophysiological control of energy balance

Brain Ceramide Metabolism in the Control of Energy Balance

International audienceThe regulation of energy balance by the central nervous system (CNS) is a key actor of energy homeostasis in mammals, and deregulations of the fine mechanisms of nutrient sensing in the brain could lead to several metabolic diseases such as obesity and type 2 diabetes (T2D). Indeed, while neuronal activity primarily relies on glucose (lactate, pyruvate), the brain expresses at high level enzymes responsible for the transport, utilization and storage of lipids. It has been demonstrated that discrete neuronal networks in the hypothalamus have the ability to detect variation of circulating long chain fatty acids (FA) to regulate food intake and peripheral glucose metabolism. During a chronic lipid excess situation, this physiological lipid sensing is impaired contributing to type 2 diabetes in predisposed subjects. Recently, different studies suggested that ceramides levels could be involved in the regulation of energy balance in both hypothalamic and extra-hypothalamic areas. Moreover, under lipotoxic conditions, these ceramides could play a role in the dysregulation of glucose homeostasis. In this review we aimed at describing the potential role of ceramides metabolism in the brain in the physiological and pathophysiological control of energy balance

Targeting sphingolipid metabolism in the treatment of obesity/type 2 diabetes

International audienc

The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice

Despite the strong correlation between non-alcoholic fatty liver disease and insulin resistance, hepatic steatosis is associated with greater whole-body insulin sensitivity in several models. We previously reported that the inhibition of hepatic glucose production (HGP) protects against the development of obesity and diabetes despite severe steatosis, thanks to the secretion of specific hepatokines such as fibroblast growth factor 21 (FGF21) and angiopoietin-related growth factor. In this work, we focused on adipose tissue to assess whether liver metabolic fluxes might, by interorgan communication, control insulin signalling in lean animals. Insulin signalling was studied in the adipose tissue of mice lacking the catalytic subunit of glucose 6-phosphatase, the key enzyme in endogenous glucose production, in the liver (L-G6pc (-/-) mice). Morphological and metabolic changes in the adipose tissues were characterised by histological analyses, gene expression and protein content. Mice lacking HGP exhibited improved insulin sensitivity of the phosphoinositide 3-kinase/Akt pathway in the subcutaneous adipose tissue associated with a browning of adipocytes. The suppression of HGP increased FGF21 levels in lean animals, and increased FGF21 was responsible for the metabolic changes in the subcutaneous adipose tissue but not for its greater insulin sensitivity. The latter might be linked to an increase in the ratio of monounsaturated to saturated fatty acids released by the liver. Our work provides evidence that HGP controls subcutaneous adipose tissue browning and insulin sensitivity through two pathways: the release of beneficial hepatokines and changes in hepatic fatty acids profile

Capture, tagging, release data and depth-profile variables for each of the 4 bluefin tunas and 7 porbeagle sharks used to compare with the 6 unknown eel predators.

<p>Capture, tagging, release data and depth-profile variables for each of the 4 bluefin tunas and 7 porbeagle sharks used to compare with the 6 unknown eel predators.</p